Filing Details

Accession Number:
0001225208-11-001464
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-01-07 11:50:19
Reporting Period:
2011-01-05
Filing Date:
2011-01-07
Accepted Time:
2011-01-07 11:50:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
901219 Human Genome Sciences Inc HGSI In Vitro & In Vivo Diagnostic Substances (2835) 223178468
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1307935 Thomas Watkins 14200 Shady Grove Road
Rockville MD 20850
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-01-05 60,000 $24.16 66,000 No 4 P Indirect By Children
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Children
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 166,075 Direct
Footnotes
  1. Shares acquired by Mr. Watkins' children as a gift from Mr. Watkins' father, who does not share his household. 20,000 shares by Caroline S. Watkins, 20,000 shares by Catherine R. Watkins and 20,000 shares by Hays T. Watkins IV. Mr. Watkins disclaims any beneficial ownership of these shares, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the shares for purposes of Section 16 or for any other purpose.